Cargando…
Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case
BACKGROUND: High pharmaceutical expenditure is one of the main concerns for policymakers worldwide. In Colombia, a middle-income country, outpatient prescription represents over 10% of total health expenditure in the mandatory benefits package (POS), and close to 90% in the complementary government...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833155/ https://www.ncbi.nlm.nih.gov/pubmed/29507533 http://dx.doi.org/10.1186/s12962-018-0092-0 |